Literature DB >> 29057662

Biomarkers of propofol metabolism in neonates: the quest beyond ontogeny.

Anne Smits1, Pieter Annaert2, Karel Allegaert3,4.   

Abstract

Keywords:  covariate; genetic variants; metabolism; neonate; ontogeny; pharmacodynamics; pharmacokinetics; postmenstrual age; postnatal age; propofol

Mesh：

Substances：

Year:  2017        PMID： 29057662     DOI： 10.2217/bmm-2017-0184

Source DB:  PubMed          Journal:  Biomark Med        ISSN： 1752-0363            Impact factor:   2.851


× No keyword cloud information.
  4 in total

Review 1.  Potential implications of DMET ontogeny on the disposition of commonly prescribed drugs in neonatal and pediatric intensive care units.

Authors:  Siavosh Naji-Talakar; Sheena Sharma; Leslie A Martin; Derek Barnhart; Bhagwat Prasad
Journal:  Expert Opin Drug Metab Toxicol       Date:  2021-01-20       Impact factor: 4.481

2.  Multi-drug therapy for epilepsy influenced bispectral index after a bolus propofol administration without affecting propofol's pharmacokinetics: a prospective cohort study.

Authors:  Matsuri Kodama; Hitoshi Higuchi; Minako Ishii-Maruhama; Mai Nakano; Yuka Honda-Wakasugi; Shigeru Maeda; Takuya Miyawaki
Journal:  Sci Rep       Date:  2020-01-31       Impact factor: 4.379

Review 3.  Clinical Importance of Potential Genetic Determinants Affecting Propofol Pharmacokinetics and Pharmacodynamics.

Authors:  Ivana Budic; Tatjana Jevtovic Stoimenov; Dimitrije Pavlovic; Vesna Marjanovic; Ivona Djordjevic; Marija Stevic; Dusica Simic
Journal:  Front Med (Lausanne)       Date:  2022-02-28

Review 4.  Metabolic Profiles of Propofol and Fospropofol: Clinical and Forensic Interpretative Aspects.

Authors:  Ricardo Jorge Dinis-Oliveira
Journal:  Biomed Res Int       Date:  2018-05-24       Impact factor: 3.411
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.